Cancel
LifeMine Therapeutics
See Linkedin
LifeMine Therapeutics Employees
18 people indexed:
-
zggqa@kzq44yqz2u.u1k Sign up to see email
-
493@822pv4g819.9qs Sign up to see email
-
78ysdkqq@z391wsuquz.94y Sign up to see email
-
4u3k0b3@kwz9z17qgj.yq7 Sign up to see email
-
08z5p15s@pj950kwqp9.6y1 Sign up to see email
-
zgp6@j4vuwbu84g.4g4 Sign up to see email
-
zsqq2gy6@ysdkqu7431.y56 Sign up to see email
-
sys9zyv@93d45z5j0j.v30 Sign up to see email
-
zdb11q9j7@24gbu296rz.839 Sign up to see email
-
jwp@drjaz2kawa.111 Sign up to see email
-
2hz95k211h@7r29zg5jrv.wj2 Sign up to see email
-
kw6gyw@pp0jd3dj4q.g1r Sign up to see email
-
zqv4d5jvz@hwyyd1bggz.p60 Sign up to see email
-
b9h20k936gb4z59@35j1b3288h.6gq Sign up to see email
-
a0kv3@29q5965d0j.7d2 Sign up to see email
-
k2373hv@hvr1rv6759.5hv Sign up to see email
-
jy674@b6q74adj0p.a8k Sign up to see email
-
p8.s8qq22.08@h6qb6h72y6.hu0 Sign up to see email
LifeMine Therapeutics Company Information
LifeMine Therapeutics is a pioneering company in the field of drug discovery, focusing on mining genetically-encoded small molecules (GEMs) from the biosphere. The company has developed an integrated, evolution-derived, AI- and genomically-enabled drug discovery engine that serves as a springboard for the rapid discovery of naturally inspired drugs with unique functionalities. LifeMine Therapeutics boasts a fully curated fungal genome repository of unprecedented scale and uses fungi as ‘avatars’ to identify small molecule therapeutic solutions for human diseases. Their Avatar-Rx platform combines high-throughput microbiology, data science, machine learning, genome engineering, and automation technologies, along with chemoinformatic-assisted drug optimization and state-of-the-art chemical synthesis with biotransformation. This approach aims to bring unparalleled speed, predictability, and scalability to small molecule drug discovery. The company operates from multiple sites, including Cambridge Discovery Park in Cambridge, MA, Gloucester, MA, and Basel, Switzerland. LifeMine Therapeutics was recognized as one of the ‘Fierce 15’ Biotech Companies of 2022 by Fierce Biotech and has entered a drug discovery and development alliance with GSK. The company has secured significant funding through various financing rounds, including $175 million in Series C, $50 million in Series B, and $55 million in Series A. The headquarters are located at Cambridge Discovery Park, 30 Acorn Park Drive, Cambridge, MA 02140, with additional sites at 417 Main St, 2nd Floor, Gloucester, MA 01930, and Klybeckstrasse 191, WKL 136, 4057 Basel, Switzerland.
Report inaccurate information
Report inaccurate information
